186 related articles for article (PubMed ID: 23493374)
1. Creb1-Mecp2-(m)CpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expression.
Chen Y; Shin BC; Thamotharan S; Devaskar SU
Endocrinology; 2013 Apr; 154(4):1598-611. PubMed ID: 23493374
[TBL] [Abstract][Full Text] [Related]
2. Prenatal caloric restriction enhances DNA methylation and MeCP2 recruitment with reduced murine placental glucose transporter isoform 3 expression.
Ganguly A; Chen Y; Shin BC; Devaskar SU
J Nutr Biochem; 2014 Feb; 25(2):259-66. PubMed ID: 24445052
[TBL] [Abstract][Full Text] [Related]
3. Differential methylation of the micro-RNA 7b gene targets postnatal maturation of murine neuronal Mecp2 gene expression.
Chen Y; Shin BC; Thamotharan S; Devaskar SU
Dev Neurobiol; 2014 Apr; 74(4):407-425. PubMed ID: 24039126
[TBL] [Abstract][Full Text] [Related]
4. Trans-activators regulating neuronal glucose transporter isoform-3 gene expression in mammalian neurons.
Rajakumar A; Thamotharan S; Raychaudhuri N; Menon RK; Devaskar SU
J Biol Chem; 2004 Jun; 279(25):26768-79. PubMed ID: 15054091
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1α in transactivating murine neuroblastic glucose transporter.
Thamotharan S; Raychaudhuri N; Tomi M; Shin BC; Devaskar SU
Am J Physiol Endocrinol Metab; 2013 Mar; 304(6):E583-98. PubMed ID: 23321477
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
Xiang Z; Zhou Q; Hu M; Sanders YY
J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
[TBL] [Abstract][Full Text] [Related]
8. Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain.
Guo JU; Su Y; Shin JH; Shin J; Li H; Xie B; Zhong C; Hu S; Le T; Fan G; Zhu H; Chang Q; Gao Y; Ming GL; Song H
Nat Neurosci; 2014 Feb; 17(2):215-22. PubMed ID: 24362762
[TBL] [Abstract][Full Text] [Related]
9. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing by methyl-CpG-binding proteins.
Nan X; Cross S; Bird A
Novartis Found Symp; 1998; 214():6-16; discussion 16-21, 46-50. PubMed ID: 9601009
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.
Xu M; Bian S; Li J; He J; Chen H; Ge L; Jiao Z; Zhang Y; Peng W; Du F; Mo Y; Gong A
Oncotarget; 2016 Mar; 7(12):14476-85. PubMed ID: 26910839
[TBL] [Abstract][Full Text] [Related]
12. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
[TBL] [Abstract][Full Text] [Related]
13. Effect of CREB1 promoter non-CpG island methylation on its differential expression profile on sheep ovaries associated with prolificacy.
Zhao J; Li FZ; Wu J; Yang H; Zheng J; Pang J; Meng FX; Wang F; Zhang YL
Tissue Cell; 2019 Jun; 58():61-69. PubMed ID: 31133247
[TBL] [Abstract][Full Text] [Related]
14. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
Drewell RA; Goddard CJ; Thomas JO; Surani MA
Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
[TBL] [Abstract][Full Text] [Related]
15. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
16. Temporal and spatial distribution of murine placental and brain GLUT3-luciferase transgene as a readout of in vivo transcription.
Thamotharan S; Stout D; Shin BC; Devaskar SU
Am J Physiol Endocrinol Metab; 2013 Feb; 304(3):E254-66. PubMed ID: 23193055
[TBL] [Abstract][Full Text] [Related]
17. Putative promoters within gene bodies control exon expression via TET1-mediated H3K36 methylation.
Ma L; Muhammad T; Wang H; Du G; Sakhawat A; Wei Y; Ali Khan A; Cong X; Huang Y
J Cell Physiol; 2020 Oct; 235(10):6711-6724. PubMed ID: 31994732
[TBL] [Abstract][Full Text] [Related]
18. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.
Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715
[TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone induces a putative repressor complex and chromatin modifications in the CRH promoter.
Sharma D; Bhave S; Gregg E; Uht R
Mol Endocrinol; 2013 Jul; 27(7):1142-52. PubMed ID: 23671328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
